Because the EGFR mutations enrolled in the current study (i.e., L858R expression and Exon 19 in-frame deletion) alter tumor progression and deterioration in LADC [8,38,39], a reduced occurrence of AURKA SNP rs1047972 in the population indicates that AURKA SNP rs1047972 has similar genetic variations to that of EGFR mutations, which merits further evaluation. This evidence concerns the gene EGFR and neoplasm.